Pharma majors Divi’s Laboratories and Laurus Labs are in spotlight after fresh August 2025 export data highlighted robust momentum in shipments.
Laurus Labs reported export value of USD 37.4 million in August 2025, marking a sharp 94% year-on-year rise and a 6% sequential increase. Divi’s Laboratories also posted healthy numbers with exports at USD 89 million, up 5% YoY and a strong 32% MoM growth, indicating continued traction in custom synthesis and API demand.
Among other companies, Neuland Labs stood out with exports of USD 12 million in August, surging 433% YoY and 250% MoM. Blue Jet Healthcare, however, saw exports at USD 3.9 million, lower compared with USD 8 million in August 2024 and USD 4.8 million in July 2025. Syngene International also reported weaker data with exports at USD 7 million, down from USD 12 million a year earlier and USD 8 million last month.
The divergence in export performance highlights how mid-sized players like Neuland Labs are benefiting from strong order inflows, while larger firms such as Divi’s and Laurus continue to consolidate their growth trajectory in global markets.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions.
